Skip to content
TBC
lls
  • Home
  • All Episodes
    • CAR T-cell Therapy
    • Leukemia
    • Lymphoma
    • Myelodysplastic Syndromes
    • Myeloma & Amyloidosis
    • Pediatric and AYA
    • General Treatment & Support
  • Subscribe by Email
  • About
  • FAQs
  • Visit LLS.org

Category Archives: Minimal Residual Disease (MRD)

Highlights from Attending ASH 2024

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Highlights from attending the 2023 ASH Annual Meeting

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

A Discussion on MRD: Practical Information for Providers

Jeffrey L. Wolf, MD, University of California San Francisco, San Francisco, CA

A Deeper Dive into MRD: A Conversation with Gail Roboz, MD

Gail J. Roboz, MD, Weill Cornell Medical College, New York, NY

Categories

  • All Episodes (100)
  • CAR T-cell Therapy (11)
  • Clinical Trials (4)
  • COVID-19 (7)
  • General Treatment & Support (34)
  • Genomics (3)
  • Health Equity (8)
  • Leukemia (22)
  • Lymphoma (15)
  • Minimal Residual Disease (MRD) (4)
  • Myelodysplastic Syndromes (6)
  • Myeloma & Amyloidosis (14)
  • Myeloproliferative Neoplasms (3)
  • Pediatric and AYA (13)
  • Rare Blood Cancers (4)
  • Transplantation (4)
  • Waldenström macroglobulinemia (2)

Find us on your favorite podcatchers

Apple PodcastsSpotifyAmazon MusicAndroidiHeartRadioJioSaavnPodchaserPodcast Indexby EmailRSSMore Subscribe Options
For a complete listing of continuing education programs, visit www.LLS.org/CE     |      Disclaimer
2024 Treating Blood Cancers Podcast Series – The Leukemia & Lymphoma Society